Skip to content

Novel Treatment for Rotator Cuff Tears

Ultrasonic Tenotomy as a Treatment of Partial Rotator Cuff Tear of the Supraspinatus Tendon: A Pilot Feasibility Study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05590494
Enrollment
15
Registered
2022-10-21
Start date
2022-11-07
Completion date
2028-12-01
Last updated
2026-08-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Supraspinatus Tear

Keywords

Ultrasonic tenotomy

Brief summary

The focus of this study is to examine changes in pain scores, strength, and range of motion over time following an ultrasonic tenotomy on a partial tear (\<50%) of the supraspinatus tendon of the rotator cuff.

Interventions

PROCEDUREUltrasonic tenotomy

Ultrasonic procedure as part of standard of care, as clinically indicated, to stimulate healing of the partial tear. The procedure uses ultrasound guidance that allows a needlelike device to gradually break up and remove tendinopathic tendon tissue.

Sponsors

Mayo Clinic
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
25 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

\- Evidence of partial tear (\< 50%) of the supraspinatus tendon on MRI.

Exclusion criteria

* A tear of the supraspinatus tendon greater \> 50% and any areas of full thickness tearing, concomitant tears \> 25% of other rotator cuff tendons (infraspinatus, teres minor or subscapularis), or acute tear of the glenoid labrum. * Evidence of systemic illness/infection requiring oral or IV antibiotics during the recruitment period. * Evidence of overlying skin infection or lesion at the proposed device insertion point on the shoulder. * Previous corticosteroid injection within three months. * Those individuals less than 25 and greater than 75 years of age will be excluded.

Design outcomes

Primary

MeasureTime frameDescription
Change in painBaseline, 2, 6, 12 and 24-weeks post-procedureMeasured using a visual analog scale (VAS), used to measure subjective pain, rated from 0 (no pain) to 100 (most severe pain) at rest and during activity (previously painful activities)
Change in shoulder active range of motionBaseline, 2, 6, 12 and 24-weeks post-procedureMeasured using a goniometer reported in degrees
Change in shoulder strengthBaseline, 2, 6, 12 and 24-weeks post-procedureAssessed using a hand-held dynamometer (HHD) placed distally on the forearm, just proximal to the wrist joint along the distal radius and ulna with instruction to push into the HHD with maximum force production for approximately 5 seconds.

Secondary

MeasureTime frameDescription
Change in quality of lifeBaseline, 2, 6, 12 and 24-weeks post-procedureMeasured using the SF-36 Quality of Life questionnaire which is a 36-item self-reported health survey that measures health and disability. Possible scores range from 0 to 100, with 0 indicating maximum disability, and 100 indicating no disability.

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORJacob Erickson, DO

Mayo Clinic

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 6, 2026